Does ENCORAFENIB Cause Dermatitis acneiform? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Dermatitis acneiform have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.7% of all adverse event reports for ENCORAFENIB.
60
Reports of Dermatitis acneiform with ENCORAFENIB
0.7%
of all ENCORAFENIB reports
6
Deaths
18
Hospitalizations
How Dangerous Is Dermatitis acneiform From ENCORAFENIB?
Of the 60 reports, 6 (10.0%) resulted in death, 18 (30.0%) required hospitalization, and 3 (5.0%) were considered life-threatening.
Is Dermatitis acneiform Listed in the Official Label?
Yes, Dermatitis acneiform is listed as a known adverse reaction in the official FDA drug label for ENCORAFENIB.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Dermatitis acneiform?
PANITUMUMAB (758)
FLUOROURACIL (508)
CETUXIMAB (425)
OXALIPLATIN (410)
ERLOTINIB (409)
LEUCOVORIN (252)
IRINOTECAN (242)
BEVACIZUMAB (191)
ADALIMUMAB (162)
AFATINIB (144)
Which ENCORAFENIB Alternatives Have Lower Dermatitis acneiform Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN